0001643848-17-000004.txt : 20170309 0001643848-17-000004.hdr.sgml : 20170309 20170309165631 ACCESSION NUMBER: 0001643848-17-000004 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170307 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20170309 DATE AS OF CHANGE: 20170309 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Patheon N.V. CENTRAL INDEX KEY: 0001643848 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981153534 STATE OF INCORPORATION: P7 FISCAL YEAR END: 1031 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37837 FILM NUMBER: 17679112 BUSINESS ADDRESS: STREET 1: EVERT VAN DE BEEKSTRAAT 104 CITY: AMSTERDAM SCHIPHOL STATE: P7 ZIP: 1118 CN BUSINESS PHONE: 31 (20) 622-3243 MAIL ADDRESS: STREET 1: EVERT VAN DE BEEKSTRAAT 104 CITY: AMSTERDAM SCHIPHOL STATE: P7 ZIP: 1118 CN FORMER COMPANY: FORMER CONFORMED NAME: Patheon Holdings Cooperatief U.A. DATE OF NAME CHANGE: 20150601 8-K 1 nycsr03a-1423014xv2xpatheo.htm 8-K Document

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 7, 2017
Patheon N.V.
(Exact name of registrant as specified in its charter)
The Netherlands
(State or other jurisdiction of incorporation)
001-37837
98-1153534
(Commission File Number)
(IRS Employer Identification No.)

Evert van de Beekstraat 104
 
1118 CN Amsterdam Schiphol
 
The Netherlands
N.A.
(Address of principal executive offices)
(Zip Code)
Registrant's telephone number, including area code: +31 (0)20 622 3243
N.A.
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions
(See General Instruction A.2 below):
¨
Written Communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Item 5.07
Submission of Matters to a Vote of Security Holders.
The following matters were voted upon and adopted at the 2017 Annual Meeting of Shareholders of Patheon N.V. (the "Company") held on March 7, 2017:
1.Appointment of the following persons as directors of our Board:
 
Nominee
For
Against
Abstain
Broker Non-Votes
(1a)
James C. Mullen
134,850,968
6,398,027
37,875
503,364
 
 
 
 
 
 
(1b)
Stephan B. Tanda
134,321,524
6,927,471
37,875
503,364
 
 
 
 
 
 
(1c)
Jeffrey P. McMullen
130,706,987
10,541,923
37,960
503,364
 
 
 
 
 
 
(1d)
Gary P. Pisano
134,469,958
6,778,941
37,971
503,364
 
 
 
 
 
 
(1e)
Charles I. Cogut
133,994,909
7,254,001
37,960
503,364
2.    Approval, by non-binding vote, of the compensation of the Company's named executive officers.
 
For
136,604,794
 
Against
4,646,141
 
Abstain
35,935
 
Broker Non-Votes
503,364
3.    Approval, by non-binding vote, of the frequency of the advisory vote on executive compensation.
 
1 year
141,050,520
 
2 years
5,726
 
3 years
195,012
 
Abstain
35,612
 
Broker Non-Votes
503,364
4.    Approval of the adoption of the financial statements for the fiscal year 2016.
 
For
141,550,260
 
Against
300
 
Abstain
239,674
 
Broker Non-Votes
0
5.    Discharge from liability of the members of our Board of Directors in respect of the exercise of their duties for the fiscal year 2016.
 
For
141,211,975
 
Against
37,323
 
Abstain
37,572
 
Broker Non-Votes
503,364

2

6.    Appointment of Ernst & Young LLP as the Company's independent registered public accounting firm and our statutory auditor for the fiscal year ending October 31, 2017.
 
For
141,733,371
 
Against
21,516
 
Abstain
35,347
 
Broker Non-Votes
0
7.    Re-authorization of our Board of Directors to acquire shares in the Company's own capital until September 7, 2018.
 
For
127,548,666
 
Against
14,221,795
 
Abstain
19,773
 
Broker Non-Votes
0
8.    Re-authorization of our Board of Directors to grant or issue (rights to acquire) shares until March 7, 2022.
 
For
129,168,278
 
Against
12,604,679
 
Abstain
17,277
 
Broker Non-Votes
0
9.    Re-authorization of our Board of Directors to limit or exclude preemptive rights in respect of a grant or issue of (rights to acquire) shares.
 
For
128,950,523
 
Against
12,335,456
 
Abstain
891
 
Broker Non-Votes
503,364
10.    Authorization of an amendment to the Company's 2016 Omnibus Incentive Plan.
 
For
131,111,408
 
Against
10,139,069
 
Abstain
36,393
 
Broker Non-Votes
503,364


3

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
PATHEON N.V.
 
 
 
 
 
Date: March 9, 2017
 
By: /s/ Eric Sherbet
 
 
 
Name: Eric Sherbet
Title: General Counsel and Secretary
 
 
 
 
 




4